▲ SURGE

Rallybio Corporation

+50.1%
RLYBNASDAQHealthcare2026-05-04
14.12
종가
9.41
전일 종가
+50.05%
변동률
150.2x
거래량 비율

급등 원인

관련 뉴스가 없습니다.

관련 뉴스

ImmunityBio Inc. (NASDAQ: IBRX) Investigated for Potential Feder
Gurufocus2026-04-29
Sanofi’s Amlitelimab Eczema Trial Reaches Completion, Setting Up a Key Pipeline Catalyst
Tipranks2026-03-19
ImmunityBio, Inc. (26CA.F) stock price, news, quote and history
Au.Finance.Yahoo2026-04-26
Eli Lilly’s LY3537031 Renal Study Moves Forward, Shaping Early Pipeline Expectations
Tipranks2026-04-25
Roundtable CEO James Heckman Details NASDAQ Strategy, Long-Term Focus, Capitalization Structure, and Lock-Up
Thestreet2026-04-06

기술적 분석

기술적 분석 데이터가 없습니다.

종목 상세 보기급등주 목록으로
Rallybio Corporation +50.1% 급등 분석 (2026-05-04) | Alpha Lenz